Allergy

Clinical evidence, research, and medical intelligence in Allergy.

Chlorpheniramine nasal spray label details pediatric allergy use

DailyMed label details for chlorpheniramine maleate spray outline pediatric dosing, allergy relief, warnings, and age-specific precautions.

By Dr. A. Nikhil Krishnan, MBBS · 3 days ago · 5 min read

Allergy·Nature

Machine Learning Predicts Beta-Lactam Allergy Risk in Clinic Cohort

Random Forest predicted IgE-mediated beta-lactam allergy with high internal and temporal validation performance in an Iranian allergy-clinic cohort.

3 days ago

Allergy·MHRA

MASK allergic rhinitis program aligns with CHRODIS good practice criteria

SUNFRAIL experts judged the MASK allergic rhinitis program against CHRODIS criteria and found agreement with 14 of 28…

Oct 31, 2026

Allergy·PubMed

Triple-Mite SCIT Cuts Symptoms and Medication Use in Real-World Allergy Care

Real-world data show sustained symptom and medication reductions with triple-mite SCIT for mite-induced rhinitis and asthma, with low…

Oct 26, 2026

Allergy·JNCI

ClinicalTrials.gov Chronic Spontaneous Urticaria Trials Face Transparency Scrutiny

Registry-publication linkage study examines outcome selection and reporting transparency in chronic spontaneous urticaria trials on ClinicalTrials.gov.

Oct 21, 2026

Allergy·ACC-PRO

Lycia IPO Targets Food Allergy Data for IgE Degrader LCA-0061

Lycia Therapeutics plans a $227.8 million IPO to fund phase 2 studies of its IgE-degrading food allergy program…

Oct 21, 2026

Allergy·MHRA

MHRA consults on school access to spare adrenaline nasal sprays

MHRA opens UK-wide consultation on allowing schools to keep spare adrenaline nasal sprays for children at risk of…

Oct 19, 2026

Allergy·Nature

Dietary Supplements Eased Allergic Rhinitis Symptoms in Meta-analysis

A systematic review found probiotics, plant compounds, and vitamin D reduced allergic rhinitis symptoms, though heterogeneity limits certainty.

Oct 17, 2026

Allergy

Clinical evidence, research, and medical intelligence in Allergy.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.